Disease Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
Mucocutaneous Lymph Node Syndrome
CUI: C0026691
Disease: Mucocutaneous Lymph Node Syndrome
0.880 GeneticVariation BEFREE We performed a genetic association analysis in several KD subgroups categorized by clinical characteristics using the KD-associated variants of the B lymphoid tyrosine kinase (<i>BLK</i>; rs6993775) and Fc gamma receptor II a (<i>FCGR2A</i>; rs1801274) in a large number of case (n=1,011) and control (n=4,533) samples. 30468029 2019
Mucocutaneous Lymph Node Syndrome
CUI: C0026691
Disease: Mucocutaneous Lymph Node Syndrome
0.880 GeneticVariation BEFREE Now, we show in 1,028 European KD patients that the <i>FCGR2C</i>-ORF haplotype, although nearly absent in Asians, was more strongly associated with susceptibility to KD than rs1801274 in Europeans. 30949161 2019
Mucocutaneous Lymph Node Syndrome
CUI: C0026691
Disease: Mucocutaneous Lymph Node Syndrome
0.880 GeneticVariation BEFREE In a meta-analysis with 1,461 cases and 5,302 controls, a very strong association of KD with the nonsynonymous SNP rs1801274 (p.His167Arg, previously assigned as p.His131Arg) in FCGR2A was confirmed in males (OR = 1.48, P = 1.43 × 10-7), but not in the females (OR = 1.17, P = 0.055). 28886140 2017
Mucocutaneous Lymph Node Syndrome
CUI: C0026691
Disease: Mucocutaneous Lymph Node Syndrome
0.880 GeneticVariation GWASCAT The present study demonstrates that p.His167Arg, a KD-associated FCGR2A variant, acts as a susceptibility gene in males only. 28886140 2017
Mucocutaneous Lymph Node Syndrome
CUI: C0026691
Disease: Mucocutaneous Lymph Node Syndrome
0.880 GeneticVariation BEFREE This meta-analysis demonstrates that the FCGR2A rs1801274 G-allele confers susceptibility to KD and UC. 27270653 2016
Mucocutaneous Lymph Node Syndrome
CUI: C0026691
Disease: Mucocutaneous Lymph Node Syndrome
0.880 GeneticVariation BEFREE Compared with their respective wild type counterparts, rs1801274 AG+GG genotypes and rs3818298 TC+CC genotypes were nominally associated with the reduced risk of KD (OR = 0.77, 95% CI = 0.59-0.99, P = 0.045; OR = 0.74, 95% CI = 0.56-0.98, P = 0.038). 25645453 2015
Mucocutaneous Lymph Node Syndrome
CUI: C0026691
Disease: Mucocutaneous Lymph Node Syndrome
0.880 GeneticVariation BEFREE These results further confirm that rs1801274 in the FCGR2A gene is significantly associated with increased risk of KD. 25093412 2014
Mucocutaneous Lymph Node Syndrome
CUI: C0026691
Disease: Mucocutaneous Lymph Node Syndrome
0.880 GeneticVariation BEFREE Significant susceptibility to CALs was found in KD patients with high-risk genotypes at both rs1801274 and rs2857151. 23456091 2013
Mucocutaneous Lymph Node Syndrome
CUI: C0026691
Disease: Mucocutaneous Lymph Node Syndrome
0.880 GeneticVariation BEFREE We also replicated the association of a functional SNP of FCGR2A (rs1801274, P = 1.6 × 10(-6)) identified in a recently reported GWAS of Kawasaki disease. 22446962 2012
Mucocutaneous Lymph Node Syndrome
CUI: C0026691
Disease: Mucocutaneous Lymph Node Syndrome
0.880 GeneticVariation GWASCAT Genome-wide association study identifies FCGR2A as a susceptibility locus for Kawasaki disease. 22081228 2011
Mucocutaneous Lymph Node Syndrome
CUI: C0026691
Disease: Mucocutaneous Lymph Node Syndrome
0.880 GeneticVariation GWASDB Genome-wide association study identifies FCGR2A as a susceptibility locus for Kawasaki disease. 22081228 2011